Search Results - "Simpson, George M"

Refine Results
  1. 1

    The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences by de Leon, Jose, Wang, Linda, Simpson, George M.

    Published in Schizophrenia research (01-06-2024)
    “…Nathan S. Kline was a pioneer in psychopharmacology in the United States (US). In 1952, Kline started a research unit at Rockland State Hospital, New York…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The apparent effects of ziprasidone on plasma lipids and glucose by KINGSBURY, Steven J, FAYEK, Mohamed, TRUFASIU, Dorina, ZADA, Jaafar, SIMPSON, George M

    Published in The journal of clinical psychiatry (01-05-2001)
    “…We examined the effects of ziprasidone on body mass index (BMI) and serum levels of glucose, cholesterol, and triglycerides. As part of a multicenter study…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Double-Blind Study of Clozapine Dose Response in Chronic Schizophrenia by Simpson, George M., Josiassen, Richard C., Stanilla, Joseph K., de Leon, Jose, Nair, Chand, Abraham, George, Odom-White, Aruby, Turner, Ralph M.

    Published in The American journal of psychiatry (01-11-1999)
    “…OBJECTIVE: This study explored the relative efficacy of three different doses of clozapine. METHOD: Fifty patients who met Kane et al.'s criteria for…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder by SIMPSON, George M, MAHMOUD, Ramy A, LASSER, Robert A, KUJAWA, Mary, BOSSIE, Cynthia A, TURKOZ, Ibrahim, RODRIGUEZ, Steven, GHARABAWI, Georges M

    Published in The journal of clinical psychiatry (01-08-2006)
    “…This study examined the effects of 2 doses of long-acting risperidone injection in patients with schizophrenia or schizoaffective disorder. This 52-week,…”
    Get full text
    Journal Article
  10. 10

    Weight gain during a double-blind multidosage clozapine study by DE LEON, Jose, DIAZ, Francisco J, JOSIASSEN, Richard C, COOPER, Thomas B, SIMPSON, George M

    Published in Journal of clinical psychopharmacology (01-02-2007)
    “…Possible variables associated with weight gain during clozapine treatment include dosing, treatment duration, baseline body mass index (BMI), sex, and plasma…”
    Get full text
    Journal Article
  11. 11

    Effectiveness of Switching to ziprasidone for Stable but symptomatic outpatients with schizophrenia by WEIDEN, Peter J, SIMPSON, George M, POTKIN, Steven G, O'SULLIVAN, Richard L

    Published in The journal of clinical psychiatry (01-05-2003)
    “…Many outpatients with schizophrenia experience persistent symptoms or side effects on their current antipsychotic regimen. Few studies have prospectively…”
    Get full text
    Journal Article
  12. 12

    Risperidone liquid concentrate and Oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation by CURRIER, Glenn W, SIMPSON, George M

    Published in The journal of clinical psychiatry (01-03-2001)
    “…Although agitation associated with psychosis is a common presentation in the psychiatric emergency service, there is no consensus concerning the best…”
    Get full text
    Journal Article
  13. 13

    Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia by Simpson, George M., Weiden, Peter, Pigott, Theresa, Murray, Stephen, Siu, Cynthia O., Romano, Steven J.

    Published in The American journal of psychiatry (01-08-2005)
    “…OBJECTIVE: The authors' goal was to compare the efficacy and tolerability of 6 months' treatment with flexible-dose ziprasidone and olanzapine in patients with…”
    Get full text
    Journal Article
  14. 14

    Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone by Canuso, Carla M, Youssef, Eriene A, Bossie, Cynthia A, Turkoz, Ibrahim, Schreiner, Andreas, Simpson, George M

    Published in International clinical psychopharmacology (01-07-2008)
    “…To assess the effect of paliperidone extended-release (ER) tablets in patients with acute symptoms who had previously received risperidone. Data for this…”
    Get full text
    Journal Article
  15. 15

    Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia by Simpson, George M., O'Gorman, Cedric J., Loebel, Antony, Yang, Ruoyong

    Published in CNS spectrums (01-10-2008)
    “…The long-term efficacy and tolerability of treatment with ziprasidone following a switch from prior antipsychotics was evaluated in outpatients with…”
    Get full text
    Journal Article
  16. 16

    Review of antipsychotics in children and adolescents by Kapetanovic, Suad, Simpson, George M

    Published in Expert opinion on pharmacotherapy (01-10-2006)
    “…The use of antipsychotics in children and adolescents in the clinical setting is increasing. This article reviews 77 clinical trials published in the last 10…”
    Get more information
    Journal Article
  17. 17

    Atypical antipsychotics and the burden of disease by Simpson, George M

    Published in The American journal of managed care (01-09-2005)
    “…The atypical antipsychotics are defined by improved tolerability in comparison with conventional antipsychotics. Specifically, the atypicals are substantially…”
    Get full text
    Journal Article
  18. 18

    Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia by Harvey, Philip D, Meltzer, Herbert, Simpson, George M, Potkin, Steven G, Loebel, Antony, Siu, Cynthia, Romano, Steven J

    Published in Schizophrenia research (01-02-2004)
    “…Objective: To assess changes in cognitive function in stable outpatients with schizophrenia switched to ziprasidone from conventional antipsychotics ( n=108),…”
    Get full text
    Journal Article
  19. 19

    An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression by SIMPSON, George M, SHESHAI, Adel El, LOZA, Nasser, KINGSBURY, Steven J, FAYEK, Mohamed, RADY, Ahmed, FAWZY, Waleed

    Published in The journal of clinical psychiatry (01-05-2005)
    “…Several investigations suggest that mifepristone leads to the rapid amelioration of psychotic depression. However, these studies were of short duration (1 week…”
    Get full text
    Journal Article
  20. 20